Literature DB >> 21323300

Toric intraocular lens misalignment inducing astigmatism after refractive surgery.

Adriana S Forseto1, Ricardo M Nosé, Walton Nosé.   

Abstract

PURPOSE: To report the unexpected induction of astigmatism after phacoemulsification and toric intraocular lens (IOL) implantation in an eye with previous corneal refractive surgery.
METHODS: Case report of a 46-year-old man with bilateral nuclear cataract and previous photorefractive keratectomy. Because corneal topography identified regular corneal astigmatism at the central optical zone, phacoemulsification and implantation of a one-piece hydrophobic acrylic toric IOL were performed.
RESULTS: Unexpected induction of astigmatism occurred in the first operated eye despite proper alignment of the IOL according to the preoperative calculations using simulated K values to determine toric IOL power and alignment. A retrospective qualitative analysis of corneal topography showed mismatching of the steepest meridian, leading to an off-axis IOL. Secondary IOL rotation improved both uncorrected and corrected distance visual acuity.
CONCLUSIONS: Qualitative analysis of the corneal topography is mandatory during the assessment of toric IOL alignment in eyes with previous corneal refractive surgery to identify the actual location of the steepest meridian. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 21323300     DOI: 10.3928/1081597X-20110208-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  The effect of head tilt on keratometric measurement using the IOLMaster.

Authors:  C Y Park; J R Do; S H Kim; C-Y Lim; R S Chuck
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

2.  Descemet stripping endothelial keratoplasty for a failed penetrating keratoplasty graft in a pseudophakic patient with a toric intraocular lens: a case report.

Authors:  George D Kymionis; George A Kontadakis
Journal:  BMC Ophthalmol       Date:  2013-10-30       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.